Reflections on a Virtual Year for the Clinical Research Industry
The year 2020 will be remembered for many reasons—COVID-19, social unrest, a U.S. presidential election, and a dramatic shift in how the clinical research industry connects. One of the most notable changes was the move from in-person conferences to fully virtual events. After attending industry meetings for more than two decades, I felt it was worth reflecting on what was gained, what was lost, and what this shift may mean moving forward.
A Longstanding Perspective on DIA
I have attended the annual Drug Information Association (DIA) conference every year since 1997. In a typical year, DIA draws between 5,000 and 8,000 attendees. In its virtual format, attendance dropped to approximately 1,500 participants.
A casual review of the attendee list suggested that many attended primarily for continuing education (CE) credits. This led some of us to speculate that roughly 1,500 people attend DIA for education alone, while another 3,500–5,000 attend largely for networking, business meetings, and relationship building.
What Was Missing Without In-Person Events
Several changes stood out immediately.
First, there was no FOCM and Zymewire Clinical ReConnections networking event on Sunday night. That absence was felt. DIA has always been an industry reunion, and not seeing friends and long-standing connections in person made relationship maintenance more difficult.
Second, fewer senior-level professionals and business development leaders attended. Without networking and social events, the incentive to participate seemed lower for many.
Third, the virtual exhibit hall lacked the energy of prior years. I usually walk the entire exhibit floor to reconnect with colleagues and discover new products and services. While I appreciated those who took time to meet virtually, the experience simply wasn’t the same.
Unexpected Benefits of Going Virtual
There were also lighter observations. I didn’t stay out late—there were no vendor-sponsored evening events. On the final day, I wasn’t exhausted, which alone marked a major change.
Interestingly, virtual one-on-one meetings often led to deeper conversations. Without hallway interruptions or distractions, discussions felt more focused and intentional. In some cases, this resulted in stronger connections than those formed during crowded in-person conferences.
New Models for Ongoing Engagement
The CNS Summit offered a compelling alternative approach by transitioning into a year-round virtual community. Rather than limiting interaction to a few days, the platform now supports ongoing education, collaboration, and networking throughout the year. This model may represent a sustainable future for certain industry gatherings.
Pride in the Industry’s Role
Despite the challenges, the clinical research industry has much to be proud of. Researchers, sponsors, CROs, and regulators demonstrated the value of collaboration through the rapid development of COVID-19 treatments and vaccines.
Advances in big data, artificial intelligence, high-throughput screening, and streamlined regulatory processes proved essential—not just for COVID-19, but for accelerating innovation across all disease areas.
Looking Ahead
While virtual conferences cannot fully replace in-person interaction, they have shown us new ways to connect and collaborate. The lessons from 2020 will continue to shape how the industry engages, learns, and builds relationships in the years ahead.
About GLSA
GlobalLifeSciencesAlliance.com (GLSA) connects biotechs, pharma, CROs, and clinical research sites with the right experts, advisors, and solutions to accelerate development and reduce risk. With a network of more than 200 trusted partners spanning pre-clinical and clinical research, GLSA offers flexible, cost-effective access to specialized expertise and services that support early-stage biotechs, mid-size pharma, and global pharmaceutical companies.
When you need trusted, global resources to accelerate your research, GLSA helps you scale smarter and move you forward with confidence.
To learn how GLSA can support your organization, connect with Denise McNerney or Chris Matheus for a conversation about your goals and challenges.